{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:37:34Z","timestamp":1790811454343,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,4]]},"DOI":"10.7759\/cureus.10248","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T18:53:11Z","timestamp":1599245591000},"source":"Crossref","is-referenced-by-count":19,"title":["Myasthenia Gravis and its Association With Thyroid Diseases"],"prefix":"10.7759","author":[{"given":"Saba","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myat","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenil R","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A","family":"Pena Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azouba","family":"Gulraiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal Haider","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00169","article-title":"Autoimmune thyroiditis and myasthenia gravis","volume":"13","author":"Lopomo A","year":"2017","unstructured":"Lopomo A, Berrih-Aknin S. Autoimmune thyroiditis and myasthenia gravis. Front Endocrinol. 2017, 13:169. 10.3389\/fendo.2017.00169","journal-title":"Front Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjem.2015.03.002","article-title":"Myasthenia gravis with acute respiratory failure in the emergency department","volume":"16","author":"Kozak HH","year":"2016","unstructured":"Kozak HH, Uca AU, Teke T, Altas M, Karatas E. Myasthenia gravis with acute respiratory failure in the emergency department. Turk J Emerg Med. 2016, 16:80-82. 10.1016\/j.tjem.2015.03.002","journal-title":"Turk J Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/tjo.tjo_39_17","article-title":"Update on ocular myasthenia gravis in Taiwan","volume":"8","author":"Lin CW","year":"2018","unstructured":"Lin CW, Chen TC, Jou JR, Woung LC. Update on ocular myasthenia gravis in Taiwan. Taiwan J Ophthalmol. 2018, 8:67. 10.4103\/tjo.tjo_39_17","journal-title":"Taiwan J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7532-3","article-title":"Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis","volume":"262","author":"Iorio R","year":"2015","unstructured":"Iorio R, Damato V, Alboini PE, Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol. 2015, 262:1115-1119. 10.1007\/s00415-014-7532-3","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.165393","article-title":"Neurological manifestations of Graves' disease: a case report and review of the literature","volume":"7","author":"Mangaraj S","year":"2016","unstructured":"Mangaraj S, Choudhury AK, Mohanty BK, Baliarsinha AK. Neurological manifestations of Graves' disease: a case report and review of the literature. J Neurosci Rural Pract. 2016, 7:153-156. 10.4103\/0976-3147.165393","journal-title":"J Neurosci Rural Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/jnrp.jnrp_150_18","article-title":"See-saw relationship and its reversal after immunotherapy in a case of Graves' disease with coexisting myasthenia gravis","volume":"10","author":"Mallikarjuna SK","year":"2019","unstructured":"Mallikarjuna SK, Velayutham SS, Sowmini PR, Jeyaraj MK, Arunan S. See-saw relationship and its reversal after immunotherapy in a case of Graves' disease with coexisting myasthenia gravis. J Neurosci Rural Pract. 2019, 10:136-138. 10.4103\/jnrp.jnrp_150_18","journal-title":"J Neurosci Rural Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2019.34.59.10144","article-title":"Hypothyroidism and myasthenia: a case study","volume":"30","author":"Salhi H","year":"2019","unstructured":"Salhi H, Ajdi F. Hypothyroidism and myasthenia: a case study. Pan Afr Med J. 2019, 30:59. 10.11604\/pamj.2019.34.59.10144","journal-title":"Pan Afr Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu A","year":"2015","unstructured":"Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity. 2015, 48:362-368. 10.3109\/08916934.2015.1030614","journal-title":"Autoimmunity"},{"key":"ref9","article-title":"Autoimmune thyroid disease with myasthenia gravis in a 28-year-old male: a case report","volume":"14","author":"Masood I","year":"2009","unstructured":"Masood I, Yasir M, Aiman A, Kudyar RP. Autoimmune thyroid disease with myasthenia gravis in a 28-year-old male: a case report. Cases J. 2009, 14:8766.","journal-title":"Cases J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48","author":"Berrih-Aknin S","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun. 2014, 48:143-148. 10.1016\/j.jaut.2014.01.003","journal-title":"J Autoimmun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer N","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, et al.. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016, 263:1473-1494. 10.1007\/s00415-016-8045-z","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks S","year":"2016","unstructured":"Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016, 263:826-834. 10.1007\/s00415-015-7963-5","journal-title":"J Neurol"},{"key":"ref13","article-title":"Epidemiology of myasthenia gravis","volume":"134","author":"Pekmezovi\u0107 T","year":"2006","unstructured":"Pekmezovi\u0107 T, Lavrni\u0107 D, Jarebinski M, Apostolski S. Epidemiology of myasthenia gravis. Srp Arh Celok Lek. 2006, 134:453-456.","journal-title":"Srp Arh Celok Lek"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"Alshekhlee A","year":"2009","unstructured":"Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009, 72:1548-1554. 10.1212\/WNL.0b013e3181a41211","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.01.001","article-title":"Therapeutic options in autoimmune myasthenia gravis","volume":"6","author":"Garc\u00eda-Carrasco M","year":"2007","unstructured":"Garc\u00eda-Carrasco M, Esc\u00e1rcega RO, Fuentes-Alexandro S, Riebeling C, Cervera R. Therapeutic options in autoimmune myasthenia gravis. Autoimmun Rev. 2007, 6:373-378. 10.1016\/j.autrev.2007.01.001","journal-title":"Autoimmun Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis C","year":"2018","unstructured":"Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of myasthenia gravis. Neurol Clin. 2018, 36:311-337. 10.1016\/j.ncl.2018.01.011","journal-title":"Neurol Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1491310","article-title":"Advances in autoimmune myasthenia gravis management","volume":"18","author":"Wang S","year":"2018","unstructured":"Wang S, Breskovska I, Gandhy S, Punga AR, Guptill JT, Kaminski HJ. Advances in autoimmune myasthenia gravis management. Expert Rev Neurother. 2018, 18:573-588. 10.1080\/14737175.2018.1491310","journal-title":"Expert Rev Neurother"},{"key":"ref18","article-title":"Plasmapheresis in patients with myasthenia gravis","volume":"66","author":"Konishi T","year":"2008","unstructured":"Konishi T. Plasmapheresis in patients with myasthenia gravis. Nihon Rinsho. 2008, 66:1165-1171.","journal-title":"Nihon Rinsho"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0875-9","article-title":"Eculizumab: a review in generalized myasthenia gravis","volume":"78","author":"Dhillon S","year":"2018","unstructured":"Dhillon S. Eculizumab: a review in generalized myasthenia gravis. Drugs. 2018, 78:367-376. 10.1007\/s40265-018-0875-9","journal-title":"Drugs"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15973.1","article-title":"Recent advances in understanding and managing myasthenia gravis","volume":"7","author":"Jordan A","year":"2018","unstructured":"Jordan A, Freimer M. Recent advances in understanding and managing myasthenia gravis. F1000Res. 2018, 7:1727. 10.12688\/f1000research.15973.1","journal-title":"F1000Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.537","article-title":"Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course","volume":"6","author":"Kubiszewska J","year":"2016","unstructured":"Kubiszewska J, Szyluk B, Szczudlik P, et al.. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav. 2016, 6:e00537. 10.1002\/brb3.537","journal-title":"Brain Behav"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00649.x","article-title":"Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease","volume":"114","author":"Toth C","year":"2006","unstructured":"Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand. 2006, 114:124-132. 10.1111\/j.1600-0404.2006.00649.x","journal-title":"Acta Neurol Scand"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.3889\/oamjms.2018.110","article-title":"Myasthenia gravis and associated diseases","volume":"6","author":"Tanovska N","year":"2018","unstructured":"Tanovska N, Novotni G, Sazdova-Burneska S, et al.. Myasthenia gravis and associated diseases. Open Access Maced J Med Sci. 2018, 6:472-478.","journal-title":"Open Access Maced J Med Sci"},{"key":"ref24","article-title":"The clinical features of myasthenia gravis associated with thyroid abnormalities","volume":"49","author":"Chen YP","year":"2010","unstructured":"Chen YP, Wei DN, Chen B. The clinical features of myasthenia gravis associated with thyroid abnormalities. Zhonghua Nei Ke Za Zhi. 2010, 49:602-605.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-220153","article-title":"Hickam's dictum: myasthenia gravis presenting concurrently with Graves' disease","volume":"2017","author":"Sehgal S","year":"2017","unstructured":"Sehgal S, Rebello R, Wolmarans L, Elston M. Hickam's dictum: myasthenia gravis presenting concurrently with Graves' disease. BMJ Case Rep. 2017, 2017:bcr2017220153. 10.1136\/bcr-2017-220153","journal-title":"BMJ Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05496.x","article-title":"Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latter","volume":"63","author":"Lakhal K","year":"2008","unstructured":"Lakhal K, Blel Y, Fysekidis M, Mohammedi K, Bouadma L. Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latter. Anaesthesia. 2008, 63:876-879. 10.1111\/j.1365-2044.2008.05496.x","journal-title":"Anaesthesia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1017\/s0317167100000251","article-title":"Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease","volume":"26","author":"Nicolle MW","year":"1999","unstructured":"Nicolle MW. Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease. Can J Neurol Sci. 1999, 26:201-203. 10.1017\/s0317167100000251","journal-title":"Can J Neurol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s003470050008","article-title":"Basedow-ophthalmopathie und okul\u00e4re myasthenie [Graves ophthalmopathy and ocular myasthenia]","volume":"97","author":"Widjaja A","year":"2000","unstructured":"Widjaja A, Rademaker J, G\u00f6lkel C, Holstein A, Leifke E, Wat N. Basedow-ophthalmopathie und okul\u00e4re myasthenie [Graves ophthalmopathy and ocular myasthenia]. Ophthalmologe. 2000, 97:38-40. 10.1007\/s003470050008","journal-title":"Ophthalmologe"},{"key":"ref29","article-title":"Response to control of hyperthyroidism in patients with myasthenia gravis and thyrotoxicosis","volume":"44","author":"Teoh R","year":"1990","unstructured":"Teoh R, Chow CC, Kay R, Cockram CS, McGuire L. Response to control of hyperthyroidism in patients with myasthenia gravis and thyrotoxicosis. Br J Clin Pract. 1990, 44:742-744.","journal-title":"Br J Clin Pract"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13254","article-title":"Prevalence and risk of thyroid diseases in myasthenia gravis [PREPRINT]","author":"Chou CC","year":"2020","unstructured":"Chou CC, Huang MH, Lan WC, Kong SS, Kuo CF, Chou IJ. Prevalence and risk of thyroid diseases in myasthenia gravis [PREPRINT]. Acta Neurol Scand. 2020, 10.1111\/ane.13254","journal-title":"Acta Neurol Scand"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1979.00500450088022","article-title":"Myasthenia gravis, pernicious anemia, and Hashimoto's thyroiditis","volume":"36","author":"Krol TC","year":"1979","unstructured":"Krol TC. Myasthenia gravis, pernicious anemia, and Hashimoto's thyroiditis. Arch Neurol. 1979, 36:594-595. 10.1001\/archneur.1979.00500450088022","journal-title":"Arch Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1981.tb00250.x","article-title":"A case report of myasthenia gravis associated with Hashimoto's thyroiditis","volume":"35","author":"Hashimoto A","year":"1981","unstructured":"Hashimoto A, Hanada M, Okada S, Aoki N. A case report of myasthenia gravis associated with Hashimoto's thyroiditis. Folia Psychiatr Neurol Jpn. 1981, 35:521-525. 10.1111\/j.1440-1819.1981.tb00250.x","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/BF00326128","article-title":"Myasthenia gravis with thymoma associated with occult thyroid carcinoma","volume":"22","author":"Senga O","year":"1992","unstructured":"Senga O, Hikita H, Kinoshita T, Hara K, Miyakawa M. Myasthenia gravis with thymoma associated with occult thyroid carcinoma. Surg Today. 1992, 22:66-68. 10.1007\/BF00326128","journal-title":"Surg Today"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.4.493","article-title":"Clinical update in aspects of the management of autoimmune thyroid diseases","volume":"31","author":"Topliss DJ","year":"2016","unstructured":"Topliss DJ. Clinical update in aspects of the management of autoimmune thyroid diseases. Endocrinol Metab. 2016, 31:493-499. 10.3803\/EnM.2016.31.4.493","journal-title":"Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1586265","article-title":"Myasthenia gravis","volume":"36","author":"Drachman DB","year":"2016","unstructured":"Drachman DB. Myasthenia gravis. Semin Neurol. 2016, 36:419-24. 10.1055\/s-0036-1586265","journal-title":"Semin Neurol"},{"key":"ref36","article-title":"Autoimmune thyroid disease: mechanism, genetics, and current knowledge","volume":"18","author":"Dong YH","year":"2014","unstructured":"Dong YH, Fu DG. Autoimmune thyroid disease: mechanism, genetics, and current knowledge. Eur Rev Med Pharmacol Sci. 2014, 18:3611-3618.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE, Skeie GO, Romi F, Lazaridis K, Zisimopoulou P, Tzartos S. Myasthenia gravis\u2014autoantibody characteristics and their implications for therapy. Nat Rev Neurol. 2016, 12:259-268. 10.1038\/nrneurol.2016.44","journal-title":"Nat Rev Neurol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson DL","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997, 84:223-243. 10.1006\/clin.1997.4412","journal-title":"Clin Immunol Immunopathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli A","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015, 14:174-180. 10.1016\/j.autrev.2014.10.016","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39269-myasthenia-gravis-and-its-association-with-thyroid-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:17Z","timestamp":1707506777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39269-myasthenia-gravis-and-its-association-with-thyroid-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.10248","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,4]]}}}